Search
for
Sort by
Research 151–180 of 465
- Editorial: Prevention and treatment of skin diseases
- Dermatological manifestations and associated factors in patients with Graves\' disease in Dakar
- Dermatological Manifestations of COVID-19: A Brief Review
- Cutaneous Lupus Erythematosus
- Fever and rash as initial signs of systemic autoimmune disease. Case Report.
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- The COVID-19 pandemic and its skin effects
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Safety Evaluation of Topical Valproate Application
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- A rash diagnosis
- Rare and common manifestations of COVID‐19 in children
- “PRIDE” Complex
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Skin Manifestations of Rheumatological Diseases
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Genetic Hair Disorders: A Review